The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The primary aim of this study was to determine the proportion of patients with esophageal
eosinophilic infiltration that have objective (measurable) evidence of gastroesophageal
reflux disease (GERD).
This study was also done to see if patients that have eosinophilic esophagitis (EE) and GERD
would receive relief from taking the medication Nexium or a steroid called Pulmicort.
The study also evaluated the accuracy of pH monitoring (acid exposure) within the esophagus
as a predictor of endoscopic, histological and symptomatic response in patients with EE.